Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Am J Gastroenterol. 2014 Jan 7;109(3):417–426. doi: 10.1038/ajg.2013.442

Table 4.

Percent Increase in Patients with a Polyp, Adenoma or Serrated Polyp Detected and in Attributable Risk, Assuming a Minimum Mandated Normal Withdrawal Time (NWT)

Assumed
minimum
NWT
(minutes)1
Percent
increase in
patients with
findings
95% CI Percent
increase in
attributable
risk (AR)2
95% CI p-value
Polyps
7 0.96 (0.32, 2.23) 2.02 (0.69, 4.72) 0.14
8 2.18 (0.68, 3.68) 4.59 (1.42, 7.77) 0.004
9 6.16 (3.69, 8.62) 12.97 (7.77, 18.17) <0.0001
10 4.19 (2.18, 6.20) 8.82 (4.53, 13.12) <0.0001
Adenomas
7 0.72 (0.13, 1.56) 2.65 (0.47, 5.77) 0.10
8 1.53 (0.62, 2.44) 5.65 (2.28, 9.02) 0.001
9 3.79 (1.80, 5.78) 14.01 (6.59, 21.42) <0.0001
10 2.51 (1.08, 3.94) 9.27 (4.06, 14.48) 0.001
Serrated Polyps
7 0.71 (0.11, 1.31) 8.51 (1.17, 15.86) 0.02
8 1.03 (0.16, 1.91) 12.40 (2.48, 22.32) 0.02
9 2.39 (0.90, 3.87) 28.59 (12.40, 44.78) 0.002
10 1.90 (0.52, 3.28) 22.75 (6.30, 39.19) 0.01
1

In this analysis, all NWTs below the ‘assumed minimum NWT’ were replaced with that assumed minimum, and the percentage increase in findings that would result was calculated

2

Attributable Risk represents the proportional increase in detection rate: the new estimated detection rate based on the assumed minimum NWT minus the baseline detection rate, divided by the baseline detection